Mahato Basudev, Prodhan Chandraday, Mandal Samir, Dutta Avirup, Kumar Parna, Deb Tushar, Jha Tarun, Chaudhuri Keya
Department of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, West Bengal, India.
Oral Health Division, Multidisciplinary Organizations for Technical and Health Education and Research, Kolkata, West Bengal, India.
Contemp Clin Dent. 2019 Jul-Sep;10(3):531-541. doi: 10.4103/ccd.ccd_937_18.
Oral submucous fibrosis (OSMF) is a high-risk premalignant condition of the oral cavity and oropharynx. Complete regression of the disease is still not possible with available treatment modalities.
The aim of the study was to evaluate the efficacy of curcumin, lycopene, and piperine as a combination in the management of OSMF.
Efficacy was evaluated on the basis of improvement in clinical parameters (i.e., visual Analog Scale [VAS]) score for burning sensation, mouth opening (MO), mucosal flexibility (MF), and tongue protrusion [TP]).
Forty patients clinically and histopathologically diagnosed with OSMF were included in the study; patients were administered with the above-stated drug combination, and clinical parameters were evaluated at regular intervals to compare the pre- and post-treatment measurements.
Paired -test was done to evaluate significance of the results.
Highly significant improvement was observed for posttreatment reduction in VAS score for burning sensation and increase in MO ( < 0.001). Significant improvement was also observed in the increase of MF and TP. Posttreatment histopathological evaluation also revealed reepithelialization, indicated by significant increase in the epithelial thickness as found through quantitative image analysis. Immunohistochemical studies with Col1A1 showed decrease in collagen deposition.
Taken together, the present study proposes the usage of combination drug therapy for the management of OSMF as an effective and affordable way.
口腔黏膜下纤维化(OSMF)是口腔和口咽的一种高危癌前病变。现有的治疗方式仍无法使该病完全消退。
本研究的目的是评估姜黄素、番茄红素和胡椒碱联合使用在治疗口腔黏膜下纤维化中的疗效。
根据临床参数(即视觉模拟量表[VAS]评分)的改善情况来评估疗效,这些参数包括烧灼感、张口度(MO)、黏膜柔韧性(MF)和伸舌度(TP)。
本研究纳入了40例经临床和组织病理学诊断为口腔黏膜下纤维化的患者;给患者服用上述药物组合,并定期评估临床参数,以比较治疗前后的测量结果。
采用配对t检验来评估结果的显著性。
治疗后烧灼感的VAS评分降低以及张口度增加,差异具有高度显著性(P<0.001)。黏膜柔韧性和伸舌度的增加也有显著改善。治疗后的组织病理学评估还显示有上皮再形成,通过定量图像分析发现上皮厚度显著增加即表明了这一点。对Col1A1进行的免疫组织化学研究显示胶原沉积减少。
综上所述,本研究提出联合药物疗法可作为一种有效且经济实惠的方法用于治疗口腔黏膜下纤维化。